+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review

Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Integra LifeSciences Holdings Corp (Integra) is a medical technology company that develops and manufactures engineered collagen-based product lines. The company’s portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. Its neurosurgery products include ultrasonic surgery systems, systems for the measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra’s products find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and extensive network of distributors worldwide. Integra is headquartered in Plainsboro, New Jersey, the US.

Integra LifeSciences Holdings Corp Key Recent Developments

  • Jan 11, 2023: Integra LifeSciences Reports Select Preliminary Fourth Quarter and Full-Year 2022 Financials
  • Dec 02, 2022: Integra LifeSciences agrees to buy Surgical Innovation Associates
  • Oct 26, 2022: Integra LifeSciences Reports Third Quarter 2022 Financial Results
  • Oct 06, 2022: Integra LifeSciences Announces Key Executive Appointment

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Integra LifeSciences Holdings Corp - Key Facts
  • Integra LifeSciences Holdings Corp - Key Employees
  • Integra LifeSciences Holdings Corp - Key Employee Biographies
  • Integra LifeSciences Holdings Corp - Major Products and Services
  • Integra LifeSciences Holdings Corp - History
  • Integra LifeSciences Holdings Corp - Company Statement
  • Integra LifeSciences Holdings Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Integra LifeSciences Holdings Corp - Business Description
  • Business Segment: Codman Specialty Surgical
  • Overview
  • Performance
  • Business Segment: Tissue Technologies
  • Overview
  • Performance
  • Geographical Segment: Asia Pacific
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Rest of World
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • Integra LifeSciences Holdings Corp - Corporate Strategy
  • Integra LifeSciences Holdings Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Integra LifeSciences Holdings Corp - Strengths
  • Integra LifeSciences Holdings Corp - Weaknesses
  • Integra LifeSciences Holdings Corp - Opportunities
  • Integra LifeSciences Holdings Corp - Threats
  • Integra LifeSciences Holdings Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • Integra LifeSciences Holdings Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jan 11, 2023: Integra LifeSciences Reports Select Preliminary Fourth Quarter and Full-Year 2022 Financials
  • Dec 02, 2022: Integra LifeSciences agrees to buy Surgical Innovation Associates
  • Oct 26, 2022: Integra LifeSciences Reports Third Quarter 2022 Financial Results
  • Oct 06, 2022: Integra LifeSciences Announces Key Executive Appointment
  • Aug 16, 2022: Integra LifeSciences Announces the Passing of Dr. Richard Caruso, Founder and Former Chairman and CEO
  • Aug 15, 2022: INTEGRA pipetting solutions streamline molecular diagnostics
  • Jul 27, 2022: Integra LifeSciences Reports Second Quarter 2022 Financial Results
  • Jul 19, 2022: Integra LifeSciences Appoints Renee Lo as Director
  • May 11, 2022: Hilco Redevelopment partners announces Integra to occupy new Braintree facility
  • Apr 27, 2022: Integra LifeSciences Reports First Quarter 2022 Financial Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Integra LifeSciences Holdings Corp, Key Facts
  • Integra LifeSciences Holdings Corp, Key Employees
  • Integra LifeSciences Holdings Corp, Key Employee Biographies
  • Integra LifeSciences Holdings Corp, Major Products and Services
  • Integra LifeSciences Holdings Corp, History
  • Integra LifeSciences Holdings Corp, Other Locations
  • Integra LifeSciences Holdings Corp, Subsidiaries
  • Integra LifeSciences Holdings Corp, Key Competitors
  • Integra LifeSciences Holdings Corp, Ratios based on current share price
  • Integra LifeSciences Holdings Corp, Annual Ratios
  • Integra LifeSciences Holdings Corp, Interim Ratios
  • Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • Integra LifeSciences Holdings Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Integra LifeSciences Holdings Corp, Performance Chart (2018 - 2022)
  • Integra LifeSciences Holdings Corp, Ratio Charts
  • Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Integra LifeSciences Holdings Corp, Medical Equipment, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Becton Dickinson and Co
  • LifeCell Corp
  • MiMedx Group Inc
  • Nexstim Plc
  • Smith & Nephew Plc
  • Stryker Corp